Can’t the audio player be displayed? Click here to listen on SoundCloud. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts.
The Food and Drug Administration was in the hot seat this week when it approved a controversial new drug for the treatment of Alzheimer’s disease with little evidence of its effectiveness.
While health policy monitors await a Supreme Court decision on a case threatening the Affordable Care Act, the Biden administration reports that a record 31 million Americans have health insurance as a direct result of the Health Act. And President Joe Biden is seeking goodwill overseas when he announces the U.S. will provide 500 million doses of Covid vaccine to aid international health efforts.
This week’s panelists are Julie Rovner from KHN, Margot Sanger-Katz from The New York Times, Joanne Kenen from Politico and Sarah Karlin-Smith from Pink Sheet.
Among the takeaways from this week’s episode:
Also this week, Rovner interviewed Chiquita Brooks-La Sure, the new administrator of the Centers for Medicare & Medicaid Services in the Department of Health and Human Services.
Panellists also recommend their favorite health policy stories of the week, which they think you should read as well, for added recognition:
Julie Rowner: HuffPost and the Center for Public Integrity “Spreading Vaccine Fears and Making Money” by Liz Essley Whyte
Politicos “What my Covid-19 vaccine saga taught me about the US healthcare system” by Joanne Kenen
Margot Sanger-Katz: The New York Times ” On That Edge of Fear ‘: One Woman’s Struggle With Sichel Cell Pain’ by John Eligon
Sarah Karlin-Smith: Pink Sheets “Patient Support May Have Helped Get Aduhelm Approved” by Derrick Gingery
Joanne Kenen: The Death of Hahnemann Hospital des New Yorkers by Chris Pomorski
To hear all of our podcasts, click here.
And subscribe to KHN’s What the Health? on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts.
Contact us Submit a story tip